Drug Trial Radar · NCT05256654
A Study of LY3561774 in Participants With Mixed Dyslipidemia
Last checked: Nov 19, 2026Latest source record: Mar 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
205
Actual
Start
Jul 20, 2022
Primary completion
Mar 4, 2024
Study completion May 23, 2024
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Feb 25, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This a multicenter, Phase 2b, double-blind, placebo-controlled, parallel group study to provide data on efficacy and safety of LY3561774 administered subcutaneously at various doses in participants with mixed dyslipidemia and on a stable dose of a statin.
Conditions
- Dyslipidemias
- Lipid Metabolism Disorders
- Metabolic Diseases
- Hyperlipoproteinemia
Interventions
LY3561774Drug
Administered SC
PlaceboDrug
Administered SC
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent Change From Baseline for Apolipoprotein B (ApoB) at Day 180Time frame: Baseline, Day 180
Locations
41 sites in 7 countries. Site status is shown where the registry gives one.
Chase Medical Research, LLC
Waterbury, Connecticut
MD Medical Research
Oxon Hill, Maryland
NECCR PrimaCare Research
Fall River, Massachusetts
Premier Research
Trenton, New Jersey
Icahn School of Medicine at Mount Sinai
New York, New York
Preferred Primary Care Physicians
Uniontown, Pennsylvania
Fundación Respirar
Buenos Aires, Argentina
Clínica Privada Velez Sarsfield
Córdoba, Argentina
Centro de Investigaciones Clinicas Instituto del Corazon (CICIC)
Córdoba, Argentina
Centro de Investigaciones Clinicas del Litoral
Santa Fe, Argentina
Centro de Investigaciones Metabólicas (CINME)
Ciudad Autónoma de Buenos Aire, Buenos Air, Argentina
Glenny Corp
Buenos Aires, Ciudad Aut, Argentina
CIPREC
CABA, Ciudad Aut, Argentina
Investigaciones Medicas Imoba Srl
Buenos Aires, Ciudad Autónoma de Buenos Aire, Argentina
Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada
Ciudad Autonoma de Buenos Aire, Ciudad Autónoma de Buenos Aire, Argentina
Sanatorio San Martin
Venado Tuerto, Santa Fe Province, Argentina
OCT Research ULC
Kelowna, British Columbia, Canada
North York Diagnostic and Cardiac Centre
North York, Ontario, Canada
Ecogene-21
Chicoutimi, Quebec, Canada
Viacar Recherche Clinique
Greenfield Park, Quebec, Canada
Clinique des Maladies Lipidiques de Québec
Québec, Quebec, Canada
AMC Nishiumeda Clinic
Osaka, Japan
Medical Corporation Heishinkai OCROM Clinic
Suita-shi, Osaka, Japan
Medical Corporation Chiseikai Tokyo Center Clinic
Chuo-ku, Tokyo, Japan
Heishinkai Medical Group ToCROM Clinic
Shinjuku-ku, Tokyo, Japan
Investigacion En Salud Y Metabolismo Sc
Chihuahua City, Mexico
Virgen Cardiovascular Research SC
Guadalajara, Jalisco, Mexico
Cardiolink Clin Trials
Monterrey, Nuevo León, Mexico
Unidad Médica para la Salud Integral
San Nicolás de los Garza, Nuevo León, Mexico
Medical Care and Research SA de CV
Mérida, Yucatán, Mexico
NZOZ Centrum Medyczne KERmed
Bydgoszcz, Kujawsko-p, Poland
Niepubliczny Zakład Opieki Zdrowotnej "Przychodnia z Sercem"
Grojec, Lesser Poland Voivodeship, Poland
Centrum Zdrowia Tuchów
Wierzchosławice, Lesser Poland Voivodeship, Poland
Samodzielny Publiczny Centralny Szpital Kliniczny w Warszawie
Warsaw, Masovian Voivodeship, Poland
Centrum Badan Klinicznych PI-House sp. z o.o.
Gdansk, Pomeranian Voivodeship, Poland
Akdeniz Universitesi Hastanesi
Antalya, Turkey (Türkiye)
Istanbul University Cerrahpasa Medical School Internal Diseases Institute
Istanbul, Turkey (Türkiye)
Kocaeli Üniversitesi
Kocaeli, Turkey (Türkiye)
Mersin University
Mersin, Turkey (Türkiye)
Ege Universitesi Hastanesi
Bornova, İzmir, Turkey (Türkiye)
Showing 40 of 41 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.